Culturally Adapted Contingency Management for Stimulant Use Disorder

This study is testing two types of behavioral therapy for Black/African American adults with stimulant use disorder (StUD). One is "Basic Contingency Management (CM)," which rewards you for providing urine samples that don't show stimulant use. The other is "Culturally Adapted Contingency Management (CM)," which is the same basic therapy but adjusted to be more relevant to Black culture. The goal is to see if the culturally adapted version works better. To join, you must be 18-65 years old, identify as Black/African American, and have a diagnosis of stimulant use disorder within the last month. Success will be measured by the percentage of negative urine samples and the longest time you stay abstinent from stimulants over 12 weeks. The current status of this study is unclear.

Study design
This is an interventional study with a planned enrollment of 70 participants. It compares two different behavioral therapies.
What's involved
Participants will attend clinic visits over 12 weeks and provide urine samples at each visit.
Compensation
Not stated in the trial record.
Follow-up
Primary outcomes are measured at Week 12.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07443332

Culturally Adapted Contingency Management

Not Yet Recruiting
NAAges 18–65InterventionalTreatment
Yale University
~70 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Cultually Adapted Contingency Management (CM)Basic Contingency Management (CM)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent negative urine samples
Measured over Week 12
+1 more outcome measured
Stimulant Use Disorders
1 sites across 1 states
Connecticut1
  • Oluwole Jegede, MD, PhD · PRINCIPAL_INVESTIGATOR · Yale University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

participants must self-identify as Black/African American
DSM-5 diagnosis of stimulant use disorder in the past month (30 days)

Exclusion

individuals who are intoxicated or otherwise unable to provide consent
  • Percent negative urine samplesWeek 12

    Participants will provide urine samples twice weekly. Percent of negative urines provided will be calculated.

  • Mean longest duration of abstinenceWeek 12

    The longest duration of abstinence in days will be measured.